| Financial Year |
March 31 2023 |
| Monetary Funds |
66,174,437,121.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
5,928,773,858.00 |
| Advances to Suppliers |
654,364,876.00 |
| Other Receivables |
4,832,517,832.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,406,670,308.00 |
| Inventories |
1,993,306,357.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
555,354,172.00 |
| Total Current Assets |
80,600,549,252.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
24,627,442,900.00 |
| Investment Properties |
-- |
| Fixed Assetes |
85,632,376,078.00 |
| Under-construction Projects |
1,956,003,956.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
9,225,206,380.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
215,793,471.00 |
| Deferred Income Tax Assets |
1,443,296,328.00 |
| Other Non-Current Assets |
56,033,935.00 |
| Sub-Total of Non-Current Assets |
123,959,834,587.00 |
| Total Assets |
204,560,383,839.00 |
| Short-Term Loans |
239,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,509,614,635.00 |
| Accounts Payable |
3,625,556,690.00 |
| Accounts Received In Advance |
11,751,874.00 |
| Employee Compensation Payable |
2,471,901,252.00 |
| Taxes Payable |
842,819,460.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,519,000,206.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
980,798,912.00 |
| Other Current Liabilities |
191,450,348.00 |
| Sub-Total of Current Liabilities |
15,371,672,813.00 |
| Long-term Loans |
11,034,049,835.00 |
| Bonds Payable |
30,385,919,608.00 |
| Long-Term Accounts Payable |
62,298,898.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
371,528,221.00 |
| Sub-Total of Non-Current Liabilities |
44,720,759,930.00 |
| Total Liabilities |
60,092,432,743.00 |
| Paid-In Capital(Or Share Stock) |
14,866,962,466.00 |
| Capital Surplus |
23,352,165,708.00 |
| Surplus Reserve |
19,412,343,151.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
70,881,576,260.00 |
| Minority Stockholder's Interest |
12,376,299,840.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
132,091,651,256.00 |
| Owner's Equity（Stockholder's Equity） |
144,467,951,096.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
204,560,383,839.00 |
